Trial Details
RECRUITINGBasic Information
| Clinical ID | c646 |
|---|---|
| Identifier | NCT06052059 |
| Trial Title | A Study to Evaluate Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderately to Severely Active Ulcerative Colitis (MK-7240-001) |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Ulcerative Colitis |
| Interventions | DRUG: IV Tulisokibart|DRUG: IV Placebo|DRUG: SC Tulisokibart|DRUG: SC Placebo |
Participant Information
| Sponsor | Merck Sharp & Dohme LLC |
|---|---|
| City | Dothan |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | CHILD, ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2023-10-25 |
|---|---|
| Primary Completion Date | 2026-11-21 |
| Completion Date | 2029-12-17 |